Have a personal or library account? Click to login

The Knops blood group system: a review

By:
Paid access
|Mar 2020

References

  1. Daniels GL, Anstee DJ, Cartron JP, et al. Blood group terminology 1995. Vox Sang 1995;69:265–79.10.1159/000462855
  2. Giles CM, Huth MC, Wilson TE, Lewis HBM, Grove GEB. Three examples of a new antibody, anti-Csa, which reacts with 98% of red cell samples. Vox Sang 1965;10:405–15.10.1111/j.1423-0410.1965.tb04354.x5851803
  3. Molthan L, Giles CM. A new antigen, Yka, and its relationship to Csa (Cost). Vox Sang 1975;29:145–53.10.1111/j.1423-0410.1975.tb00488.x1146279
  4. Helgeson M, Swanson J, Polesky HF. Knops-Helgeson (Kna), a high frequency erythrocyte antigen. Transfusion 1970;10:737–8.10.1111/j.1537-2995.1970.tb00720.x4192883
  5. Mallan MT, Grimm W, Hindley L, Knighton G, Moulds MK, Moulds JJ. The Hall serum: detecting Knb, the antithetical allele to Kna (abstract). Transfusion 1980;20:630.
  6. Molthan L, Moulds J. A new antigen, McCa (McCoy), and its relationship to Kna (Knops). Transfusion 1978;18:566–8.10.1046/j.1537-2995.1978.18579036386.x705863
  7. Lacey P, Laird-Fryer B, Block U, Lair J, Guilbeau L. Moulds JJ. A new high incidence blood group factor, Sla; and its hypothetical allele. (abstract).Transfusion 1980;20:632.
  8. Molthan L. Expansion of the York, Cost, McCoy, Knops blood group system: the new McCoy antigens McCc and McCd. Med Lab Sci 1983;40:113–21.
  9. Daniels GL, Cartron JP, Fletcher A, et al. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver report. Vox Sang 2003;84:244–7.10.1046/j.1423-0410.2003.00282.x12670376
  10. Moulds JM, Pierce S, Peck KB, Tulley ML, Doumbo O, Moulds JJ. KAM: a new allele in the Knops Blood Group System (abstract). Transfusion 2005;45(Suppl):27A.
  11. Daniels G, Castilho L, Flegel WA. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Cape Town report. Vox Sang 2007;92:250–3.10.1111/j.1423-0410.2007.00887.x17348875
  12. Covas DT, de Oliveira FS, Rodrigues ES, Abe-Sandes K, Silva WA Jr, Fontes AM. Knops blood group haplotypes among distinct Brazilian populations. Transfusion 2007;47:147–53.10.1111/j.1537-2995.2007.01077.x17207243
  13. Molthan L. The serology of the York-Cost-McCoy-Knops red blood cell system. Am J Med Technol 1983;49:49–56.
  14. Moulds JM, Kassambara L, Middleton JJ. Identification of complement receptor one (CR1) polymorphisms in west Africa. Genes Immun 2000;1:325–9.10.1038/sj.gene.636367611196694
  15. Moulds JM, Nickells MW, Moulds JJ, Brown M, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group sera. J Exp Med 1991;173:1159–63.10.1084/jem.173.5.115921188661708809
  16. Rao N, Ferguson DJ, Lee SF, Telen MJ. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991;146:3501–7.
  17. Petty AC, Green CA, Poole J, Daniels GL. Analysis of Knops blood group antigens on CR1 (CD35) by the MAIEA test and by immunoblotting. Transfus Med 1997;7:55–62.10.1046/j.1365-3148.1997.d01-71.x
  18. Moulds MK. Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies. Am J Med Technol 1981;10:789–95.
  19. Reid ME, Lomas-Francis C. Knops blood group system. In: The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004:439–54.
  20. Holme E, Fyfe A, Zoma A, Veitch J, Hunter J, Whaley K. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol 1986;63:41–8.
  21. Pascual M, Lutz HU, Steiger G, Stammler P, Schifferli JA. Release of vesicles enriched in complement receptor 1 from human erythrocytes. J Immunol 1993;151:397–404.
  22. Daniels GL, Shaw MA, Lomas CG, Leak MR, Tippett P. The effect of In(Lu) on some high-frequency antigens. Transfusion 1986;26:171–2.10.1046/j.1537-2995.1986.26286152909.x
  23. Race RR, Sanger R. Some very frequent antigens. In: Blood groups in man. 6th ed. Oxford: Blackwell Scientific Publications, 1975:410–30.
  24. Pascual M, Steiger G, Sadallah S, et al. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J Exp Med 1994;179:889–99.10.1084/jem.179.3.889
  25. Yoon SH, Fearon DT. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J Immunol 1985;134:3332–8.
  26. Danielsson C, Pascual M, Larsen B, Steiger G, Schifferli JA. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur J Immunol 1994;24:2725–31.10.1002/eji.1830241123
  27. Pascual M, Duchosal MA, Steiger G, et al. Circulating soluble CR1 (CD35). J Immunol 1993;151:1702–11.
  28. Moulds JM, Rowe KE. Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion 1996;36:517–20.10.1046/j.1537-2995.1996.36696269510.x
  29. Moulds JM, Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001;97:2879–85.10.1182/blood.V97.9.2879
  30. Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004;44:1273–81.10.1111/j.1537-2995.2004.03427.x
  31. Vik DP, Wong WW. Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele. J Immunol 1993;151:6214–24.
  32. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction fragment polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986;164:50–9.10.1084/jem.164.1.50
  33. Cornillet P, Philbert F, Kazatchkine MD, Cohen JHM. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J Immunol Methods 1991;136:193–7.10.1016/0022-1759(91)90006-2
  34. Moulds JM, Brai M, Cohen JHM, et al. Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet 1998;15:291–4.10.1159/00001908410072640
  35. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 1998;87:176–83.10.1006/clin.1998.45299614933
  36. Rowe JA, Plowe CV, Diallo DA, et al. Erythrocyte complement receptor 1 expression level does not correlate with HindIII restriction fragment length polymorphism in; implications for studies on malaria susceptibility. Genes Immun 2002;8:497–500.10.1038/sj.gene.636389912486610
  37. Cockburn IA, Rowe JA. Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3’ untranslated regions of the CR1 gene. Int J Immunogenet 2006;33:17–20.10.1111/j.1744-313X.2005.00552.x286902216426237
  38. Daniels GL, Anstee DJ, Cartron JP, et al. International Society of Blood Transfusion working party on terminology for red cell surface antigens. Vox Sang 2001;80:193–6.10.1046/j.1423-0410.2001.00024.x11449960
  39. Moulds JM, Zimmerman PA, Doumbo OK, et al. Expansion of the Knops blood group system and subdivision of Sla. Transfusion 2002;42:251–6.10.1046/j.1537-2995.2002.00002.x11896343
  40. Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte protein and complement-receptor 1. Nature 1997;388:292–5.10.1038/408889230440
  41. Rowe JA, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 1995;63:2323–6.10.1128/iai.63.6.2323-2326.19951733047768616
  42. Da Silva RP, Hall BF, Joiner KA, Sacks DL. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol 1989;143:617–22.
  43. Payne NR, Horwitz MA. Phagocytosis of legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med 1987;166:1377–89.10.1084/jem.166.5.137721896473316470
  44. Robledo S, Wozencraft A, Valencia AZ, Saravia N. Human monocyte infection by Leishmania (viannia) panamensis. J Immunol 1994;152:1265–75.
  45. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990;144:2771–80·
  46. Noumsi GT, Tounkara A, Diallo D, Moulds JM. Knops blood group polymorphism and protection from Mycobacterium tuberculosis (abstract). Transfusion 2006;46(Suppl):19A.
DOI: https://doi.org/10.21307/immunohematology-2019-193 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 2 - 7
Published on: Mar 12, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 J.M. Moulds, published by American National Red Cross
This work is licensed under the Creative Commons License.